Novo Integrated Sciences Inc (NVOS)
0.6103
-0.07
(-9.65%)
USD |
NASDAQ |
Apr 30, 16:00
0.5914
-0.02
(-3.10%)
After-Hours: 06:11
Novo Integrated Sciences Enterprise Value: 13.96M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 13.96M |
| April 29, 2024 | 15.20M |
| April 26, 2024 | 12.22M |
| April 25, 2024 | 12.34M |
| April 24, 2024 | 12.33M |
| April 23, 2024 | 12.14M |
| April 22, 2024 | 12.12M |
| April 19, 2024 | 10.93M |
| April 18, 2024 | 11.22M |
| April 17, 2024 | 12.04M |
| April 16, 2024 | 13.97M |
| April 15, 2024 | 11.09M |
| April 12, 2024 | 10.99M |
| April 11, 2024 | 11.88M |
| April 10, 2024 | 12.06M |
| April 09, 2024 | 12.45M |
| April 08, 2024 | 12.25M |
| April 05, 2024 | 10.88M |
| April 04, 2024 | 11.84M |
| April 03, 2024 | 10.64M |
| April 02, 2024 | 10.44M |
| April 01, 2024 | 10.92M |
| March 28, 2024 | 10.98M |
| March 27, 2024 | 10.72M |
| March 26, 2024 | 10.53M |
| Date | Value |
|---|---|
| March 25, 2024 | 11.01M |
| March 22, 2024 | 11.38M |
| March 21, 2024 | 11.73M |
| March 20, 2024 | 12.02M |
| March 19, 2024 | 11.60M |
| March 18, 2024 | 13.08M |
| March 15, 2024 | 12.09M |
| March 14, 2024 | 12.18M |
| March 13, 2024 | 14.19M |
| March 12, 2024 | 12.16M |
| March 11, 2024 | 11.92M |
| March 08, 2024 | 13.15M |
| March 07, 2024 | 13.51M |
| March 06, 2024 | 13.63M |
| March 05, 2024 | 13.49M |
| March 04, 2024 | 13.22M |
| March 01, 2024 | 13.69M |
| February 29, 2024 | 13.53M |
| February 28, 2024 | 12.12M |
| February 27, 2024 | 12.88M |
| February 26, 2024 | 13.12M |
| February 23, 2024 | 13.12M |
| February 22, 2024 | 13.83M |
| February 21, 2024 | 14.38M |
| February 20, 2024 | 14.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.44M
Minimum
Apr 02 2024
322.77M
Maximum
May 01 2019
68.30M
Average
55.73M
Median
Jun 24 2020
Enterprise Value Benchmarks
| American Shared Hospital Services | 26.82M |
| Astrana Health Inc | 1.444B |
| Cryo-Cell International Inc | 76.90M |
| P3 Health Partners Inc | 427.64M |
| Biote Corp | 215.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.746M |
| Revenue (Quarterly) | 3.171M |
| Total Expenses (Quarterly) | 4.710M |
| EPS Diluted (Quarterly) | -0.16 |
| Gross Profit Margin (Quarterly) | 41.76% |
| Profit Margin (Quarterly) | -86.61% |
| Earnings Yield | -104.9% |
| Normalized Earnings Yield | -111.35 |